ask="7.40"
ask_size="100"
average_daily_volume="23415"
bid="5.99"
bid_size="2000"
book_value="1.81"
change="-0.06"
change_from_200_day_moving_average="-0.57"
change_from_50_day_moving_average="-0.23"
change_from_52_week_high="-4.48"
change_From_52_week_low="0.33"
change_in_percent="-0.99%"
close="6.03"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-0.86"
ebitda="-9.95M"
eps_estimate_current_year="-0.62"
eps_estimate_next_quarter="0.00"
eps_estimate_next_year="-1.01"
ex_dividend_date="N/A"
float_shares="8775000"
high="6.21"
high_52_weeks="10.51"
last_trade_date="3/14/2017"
last_trade_price="6.03"
last_trade_size="100"
last_trade_time="3:59pm"
low="6.01"
low_52_weeks="5.70"
market_capitalization="80.10M"
moving_average_200_day="6.60"
moving_average_50_day="6.26"
name="Oramed Pharmaceuticals Inc."
notes="N/A"
one_year_target_price="19.33"
open="6.06"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="-8.68%"
percent_change_from_50_day_moving_average="-3.75%"
percent_change_from_52_week_high="-42.63%"
percent_change_from_52_week_low="+5.79%"
previous_close="6.09"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="3.37"
price_per_sales="64.66"
revenue="1.25M"
shares_outstanding="13283000"
short_ratio="10.25"
stock_exchange="NCM"
symbol="ORMP"
volume="31162"
weeks_range_52="5.70 - 10.51"
